SANDEEPAGARWALSANDEEP AGARWAL0.000000000000000.000000000000003689AGARWAL, SANDEEPAssociate Professorprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provinceAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 791062Authorship 820791Authorship 1069181Authorship 28688General Internal MedicineInfectious Diseases, Infection Control, and Employee HealthMD AndersonMARIA DE LOS ANGELESLOPEZ-OLIVOMARIA DE LOS ANGELES LOPEZ-OLIVO9353LOPEZ-OLIVO, MARIA DE LOS ANGELESAssistant ProfessorMARIASUAREZ-ALMAZORMARIA SUAREZ-ALMAZOR9347SUAREZ-ALMAZOR, MARIAProfessorAuthorship 4661328Authorship 7098560Authorship 8094355Authorship 861151Authorship 935571Authorship 993236Authorship 299745926324850Pedroza M, Le TT, Lewis K, Karmouty-Quintana H, To S, George AT, Blackburn MR, Tweardy DJ, Agarwal SKFASEB journal : official publication of the Federation of American Societies for Experimental BiologySTAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation. FASEB J. 2016 Jan; 30(1):129-40.FASEB J2015-08-31T00:00:002015STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.74Professor10Assistant Professor27Clinical Assistant Professor54Instructor14Associate Professor16Associate Professor Emeritus6Adjunct ProfessorDAVIDTWEARDYDAVID TWEARDY11776TWEARDY, DAVIDProfessor16267604Agarwal SK, Monach PA, Docken WP, Coblyn JSClinical rheumatologyCharacterization of relapses in adult idiopathic inflammatory myopathies. Clin Rheumatol. 2006 Jul; 25(4):476-81.Clin Rheumatol2005-11-03T00:00:002005Characterization of relapses in adult idiopathic inflammatory myopathies.Medicine-Epidemiology & Populat SciAuthorship 323096327036393Shagroni T, Baalwa J, Agarwal SThe American journal of medicineDouble Trouble: The Diagnostic Dilemma of Diffuse Alveolar Hemorrhage. Am J Med. 2016 Jul; 129(7):e73-4.Am J Med2016-03-29T00:00:002016Double Trouble: The Diagnostic Dilemma of Diffuse Alveolar Hemorrhage.One Baylor PlazaHouston, 77030TXAuthorship 325240427311482Row S, Liu Y, Alimperti S, Agarwal SK, Andreadis STJournal of cell scienceCadherin-11 is a novel regulator of extracellular matrix synthesis and tissue mechanics. J Cell Sci. 2016 08 01; 129(15):2950-61.J Cell Sci2016-06-16T00:00:002016Cadherin-11 is a novel regulator of extracellular matrix synthesis and tissue mechanics.18634159Agarwal SK, Glass RJ, Shadick NA, Coblyn JS, Anderson RJ, Maher NE, Weinblatt ME, Solomon DHThe Journal of rheumatologyPredictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis. J Rheumatol. 2008 Sep; 35(9):1737-44.J Rheumatol2008-07-15T00:00:002008Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis.14593853Cohen L, Baile WF, Henninger E, Agarwal SK, Kudelka AP, Lenzi R, Sterner J, Marshall GDJournal of behavioral medicinePhysiological and psychological effects of delivering medical news using a simulated physician-patient scenario. J Behav Med. 2003 Oct; 26(5):459-71.J Behav Med2003-10-01T00:00:002003Physiological and psychological effects of delivering medical news using a simulated physician-patient scenario.19596691Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK, Tan FK, McNearney T, Fischbach M, Fritzler MJ, Mayes MD, Reveille JDAnnals of the rheumatic diseasesMajor histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis. 2010 May; 69(5):822-7.Ann Rheum Dis2009-07-12T00:00:002009Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.19950257Gourh P, Agarwal SK, Divecha D, Assassi S, Paz G, Arora-Singh RK, Reveille JD, Shete S, Mayes MD, Arnett FC, Tan FKArthritis and rheumatismPolymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines. Arthritis Rheum. 2009 Dec; 60(12):3794-806.Arthritis Rheum2009-12-01T00:00:002009Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.20090527Agarwal SK, Reveille JDCurrent opinion in rheumatologyThe genetics of scleroderma (systemic sclerosis). Curr Opin Rheumatol. 2010 Mar; 22(2):133-8.Curr Opin Rheumatol2010-03-01T00:00:002010The genetics of scleroderma (systemic sclerosis).20383147Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, Coenen MJ, Vonk MC, Voskuyl AE, Schuerwegh AJ, Broen JC, van Riel PL, van 't Slot R, Italiaander A, Ophoff RA, Riemekasten G, Hunzelmann N, Simeon CP, Ortego-Centeno N, Gonz?lez-Gay MA, Gonz?lez-Escribano MF, Spanish Scleroderma Group, Airo P, van Laar J, Herrick A, Worthington J, Hesselstrand R, Smith V, de Keyser F, Houssiau F, Chee MM, Madhok R, Shiels P, Westhovens R, Kreuter A, Kiener H, de Baere E, Witte T, Padykov L, Klareskog L, Beretta L, Scorza R, Lie BA, Hoffmann-Vold AM, Carreira P, Varga J, Hinchcliff M, Gregersen PK, Lee AT, Ying J, Han Y, Weng SF, Amos CI, Wigley FM, Hummers L, Nelson JL, Agarwal SK, Assassi S, Gourh P, Tan FK, Koeleman BP, Arnett FC, Martin J, Mayes MDNature geneticsGenome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet. 2010 May; 42(5):426-9.Nat Genet2010-04-11T00:00:002010Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.20952467Assassi S, Reveille JD, Arnett FC, Weisman MH, Ward MM, Agarwal SK, Gourh P, Bhula J, Sharif R, Sampat K, Mayes MD, Tan FKThe Journal of rheumatologyWhole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5. J Rheumatol. 2011 Jan; 38(1):87-98.J Rheumatol2010-10-15T00:00:002010Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5.21779181Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M, Diaz-Gallo LM, Broen JC, Vonk MC, Simeon CP, Alizadeh BZ, Coenen MJ, Voskuyl AE, Schuerwegh AJ, van Riel PL, Vanthuyne M, van 't Slot R, Italiaander A, Ophoff RA, Hunzelmann N, Fonollosa V, Ortego-Centeno N, Gonz?lez-Gay MA, Garc?a-Hern?ndez FJ, Gonz?lez-Escribano MF, Airo P, van Laar J, Worthington J, Hesselstrand R, Smith V, de Keyser F, Houssiau F, Chee MM, Madhok R, Shiels PG, Westhovens R, Kreuter A, de Baere E, Witte T, Padyukov L, Nordin A, Scorza R, Lunardi C, Lie BA, Hoffmann-Vold AM, Palm O, Garc?a de la Pe?a P, Carreira P, Spanish Scleroderma Group, Varga J, Hinchcliff M, Lee AT, Gourh P, Amos CI, Wigley FM, Hummers LK, Nelson JL, Riemekasten G, Herrick A, Beretta L, Fonseca C, Denton CP, Gregersen PK, Agarwal S, Assassi S, Tan FK, Arnett FC, Radstake TR, Mayes MD, Martin JPLoS geneticsIdentification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet. 2011 Jul; 7(7):e1002178.PLoS Genet2011-07-14T00:00:002011Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.21926187Carmona FD, Gutala R, Sime?n CP, Carreira P, Ortego-Centeno N, Vicente-Rabaneda E, Garc?a-Hern?ndez FJ, Garc?a de la Pe?a P, Fern?ndez-Castro M, Mart?nez-Estupi??n L, Egurbide MV, Tsao BP, Gourh P, Agarwal SK, Assassi S, Mayes MD, Arnett FC, Tan FK, Mart?n J, Spanish Scleroderma GroupAnnals of the rheumatic diseasesNovel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis. Ann Rheum Dis. 2012 Jan; 71(1):114-9.Ann Rheum Dis2011-09-16T00:00:002011Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis.22073935Agarwal SKJournal of managed care pharmacy : JMCPBiologic agents in rheumatoid arthritis: an update for managed care professionals. J Manag Care Pharm. 2011 Nov-Dec; 17(9 Suppl B):S14-8.J Manag Care Pharm2011-11-01T00:00:002011Biologic agents in rheumatoid arthritis: an update for managed care professionals.16582691Agarwal SK, Brenner MBCurrent opinion in rheumatologyRole of adhesion molecules in synovial inflammation. Curr Opin Rheumatol. 2006 May; 18(3):268-76.Curr Opin Rheumatol2006-05-01T00:00:002006Role of adhesion molecules in synovial inflammation.16651616Kiener HP, Lee DM, Agarwal SK, Brenner MBThe American journal of pathologyCadherin-11 induces rheumatoid arthritis fibroblast-like synoviocytes to form lining layers in vitro. Am J Pathol. 2006 May; 168(5):1486-99.Am J Pathol2006-05-01T00:00:002006Cadherin-11 induces rheumatoid arthritis fibroblast-like synoviocytes to form lining layers in vitro.18329530Agarwal SK, Tan FK, Arnett FCRheumatic diseases clinics of North AmericaGenetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am. 2008 Feb; 34(1):17-40; v.Rheum Dis Clin North Am2008-02-01T00:00:002008Genetics and genomic studies in scleroderma (systemic sclerosis).19796918Gourh P, Agarwal SK, Martin E, Divecha D, Rueda B, Bunting H, Assassi S, Paz G, Shete S, McNearney T, Draeger H, Reveille JD, Radstake TR, Simeon CP, Rodriguez L, Vicente E, Gonzalez-Gay MA, Mayes MD, Tan FK, Martin J, Arnett FCJournal of autoimmunityAssociation of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J Autoimmun. 2010 Mar; 34(2):155-62.J Autoimmun2009-09-30T00:00:002009Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.19778912Gourh P, Arnett FC, Tan FK, Assassi S, Divecha D, Paz G, McNearney T, Draeger H, Reveille JD, Mayes MD, Agarwal SKAnnals of the rheumatic diseasesAssociation of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis. Ann Rheum Dis. 2010 Mar; 69(3):550-5.Ann Rheum Dis2009-09-23T00:00:002009Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis.19799786Gourh P, Arnett FC, Assassi S, Tan FK, Huang M, Diekman L, Mayes MD, Reveille JD, Agarwal SKArthritis research & therapyPlasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations. Arthritis Res Ther. 2009; 11(5):R147.Arthritis Res Ther2009-10-02T00:00:002009Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.19918037Agarwal SK, Gourh P, Shete S, Paz G, Divecha D, Reveille JD, Assassi S, Tan FK, Mayes MD, Arnett FCThe Journal of rheumatologyAssociation of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis. J Rheumatol. 2009 Dec; 36(12):2715-23.J Rheumatol2009-11-16T00:00:002009Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis.Authorship 702122228087506Smolen JS, Agarwal SK, Ilivanova E, Xu XL, Miao Y, Zhuang Y, Nnane I, Radziszewski W, Greenspan A, Beutler A, Baker DAnnals of the rheumatic diseasesA randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Ann Rheum Dis. 2017 May; 76(5):831-839.Ann Rheum Dis2017-01-13T00:00:002017A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate.21790287Barnes J, Agarwal SKExpert review of clinical immunologyTargeting STAT4 in systemic sclerosis: a promising new direction. Expert Rev Clin Immunol. 2011 Jul; 7(4):445-8.Expert Rev Clin Immunol2011-07-01T00:00:002011Targeting STAT4 in systemic sclerosis: a promising new direction.21990376Schneider DJ, Wu M, Le TT, Cho SH, Brenner MB, Blackburn MR, Agarwal SKFASEB journal : official publication of the Federation of American Societies for Experimental BiologyCadherin-11 contributes to pulmonary fibrosis: potential role in TGF-? production and epithelial to mesenchymal transition. FASEB J. 2012 Feb; 26(2):503-12.FASEB J2011-10-11T00:00:002011Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-? production and epithelial to mesenchymal transition.21094920McCray CJ, Agarwal SKImmunology and allergy clinics of North AmericaStress and autoimmunity. Immunol Allergy Clin North Am. 2011 Feb; 31(1):1-18.Immunol Allergy Clin North Am2011-02-01T00:00:002011Stress and autoimmunity.21362770Coustet B, Agarwal SK, Gourh P, Guedj M, Mayes MD, Dieude P, Wipff J, Avouac J, Hachulla E, Diot E, Cracowski JL, Tiev K, Sibilia J, Mouthon L, Frances C, Amoura Z, Carpentier P, Meyer O, Kahan A, Boileau C, Arnett FC, Allanore YThe Journal of rheumatologyAssociation study of ITGAM, ITGAX, and CD58 autoimmune risk loci in systemic sclerosis: results from 2 large European Caucasian cohorts. J Rheumatol. 2011 Jun; 38(6):1033-8.J Rheumatol2011-03-01T00:00:002011Association study of ITGAM, ITGAX, and CD58 autoimmune risk loci in systemic sclerosis: results from 2 large European Caucasian cohorts.21572159Sharif R, Fritzler MJ, Mayes MD, Gonzalez EB, McNearney TA, Draeger H, Baron M, Canadian Scleroderma Research Group, Furst DE, Khanna DK, del Junco DJ, Molitor JA, Schiopu E, Phillips K, Seibold JR, Silver RM, Simms RW, GENISOS Study Group, Perry M, Rojo C, Charles J, Zhou X, Agarwal SK, Reveille JD, Assassi S, Arnett FCThe Journal of rheumatologyAnti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis. J Rheumatol. 2011 Aug; 38(8):1622-30.J Rheumatol2011-05-15T00:00:002011Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.22073933Agarwal SKJournal of managed care pharmacy : JMCPCore management principles in rheumatoid arthritis to help guide managed care professionals. J Manag Care Pharm. 2011 Nov-Dec; 17(9 Suppl B):S03-8.J Manag Care Pharm2011-11-01T00:00:002011Core management principles in rheumatoid arthritis to help guide managed care professionals.22073934Farheen K, Agarwal SKJournal of managed care pharmacy : JMCPAssessment of disease activity and treatment outcomes in rheumatoid arthritis. J Manag Care Pharm. 2011 Nov-Dec; 17(9 Suppl B):S09-13.J Manag Care Pharm2011-11-01T00:00:002011Assessment of disease activity and treatment outcomes in rheumatoid arthritis.22402440Wu M, Schneider DJ, Mayes MD, Assassi S, Arnett FC, Tan FK, Blackburn MR, Agarwal SKThe Journal of investigative dermatologyOsteopontin in systemic sclerosis and its role in dermal fibrosis. J Invest Dermatol. 2012 Jun; 132(6):1605-14.J Invest Dermatol2012-03-08T00:00:002012Osteopontin in systemic sclerosis and its role in dermal fibrosis.22440820Sharif R, Mayes MD, Tan FK, Gorlova OY, Hummers LK, Shah AA, Furst DE, Khanna D, Martin J, Bossini-Castillo L, Gonzalez EB, Ying J, Draeger HT, Agarwal SK, Reveille JD, Arnett FC, Wigley FM, Assassi SAnnals of the rheumatic diseasesIRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Ann Rheum Dis. 2012 Jul; 71(7):1197-202.Ann Rheum Dis2012-03-22T00:00:002012IRF5 polymorphism predicts prognosis in patients with systemic sclerosis.Authorship 870236728575534Wu M, Baron M, Pedroza C, Salazar GA, Ying J, Charles J, Agarwal SK, Hudson M, Pope J, Zhou X, Reveille JD, Fritzler MJ, Mayes MD, Assassi SArthritis & rheumatology (Hoboken, N.J.)CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts. Arthritis Rheumatol. 2017 09; 69(9):1871-1878.Arthritis Rheumatol2017-08-08T00:00:002017CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts.17255475Lee DM, Kiener HP, Agarwal SK, Noss EH, Watts GF, Chisaka O, Takeichi M, Brenner MBScience (New York, N.Y.)Cadherin-11 in synovial lining formation and pathology in arthritis. Science. 2007 Feb 16; 315(5814):1006-10.Science2007-01-25T00:00:002007Cadherin-11 in synovial lining formation and pathology in arthritis.18383368Agarwal SK, Lee DM, Kiener HP, Brenner MBArthritis and rheumatismCoexpression of two mesenchymal cadherins, cadherin 11 and N-cadherin, on murine fibroblast-like synoviocytes. Arthritis Rheum. 2008 Apr; 58(4):1044-54.Arthritis Rheum2008-04-01T00:00:002008Coexpression of two mesenchymal cadherins, cadherin 11 and N-cadherin, on murine fibroblast-like synoviocytes.20112391Assassi S, Mayes MD, Arnett FC, Gourh P, Agarwal SK, McNearney TA, Chaussabel D, Oommen N, Fischbach M, Shah KR, Charles J, Pascual V, Reveille JD, Tan FKArthritis and rheumatismSystemic sclerosis and lupus: points in an interferon-mediated continuum. Arthritis Rheum. 2010 Feb; 62(2):589-98.Arthritis Rheum2010-02-01T00:00:002010Systemic sclerosis and lupus: points in an interferon-mediated continuum.20807474Agarwal SKDiscovery medicineThe genetics of systemic sclerosis. Discov Med. 2010 Aug; 10(51):134-43.Discov Med2010-08-01T00:00:002010The genetics of systemic sclerosis.20882258Lindsey JW, Agarwal SK, Tan FKMolecular medicine (Cambridge, Mass.)Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cells. Mol Med. 2011 Jan-Feb; 17(1-2):95-102.Mol Med2010-09-17T00:00:002010Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cells.21223583Agarwal SK, Wu M, Livingston CK, Parks DH, Mayes MD, Arnett FC, Tan FKArthritis research & therapyToll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts. Arthritis Res Ther. 2011 Jan 11; 13(1):R3.Arthritis Res Ther2011-01-11T00:00:002011Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts.22076442Bossini-Castillo L, Martin JE, Broen J, Gorlova O, Sime?n CP, Beretta L, Vonk MC, Callejas JL, Castellv? I, Carreira P, Garc?a-Hern?ndez FJ, Fern?ndez Castro M, Spanish Scleroderma Group, Coenen MJ, Riemekasten G, Witte T, Hunzelmann N, Kreuter A, Distler JH, Koeleman BP, Voskuyl AE, Schuerwegh AJ, Palm ?, Hesselstrand R, Nordin A, Air? P, Lunardi C, Scorza R, Shiels P, van Laar JM, Herrick A, Worthington J, Denton C, Tan FK, Arnett FC, Agarwal SK, Assassi S, Fonseca C, Mayes MD, Radstake TR, Martin JHuman molecular geneticsA GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. Hum Mol Genet. 2012 Feb 15; 21(4):926-33.Hum Mol Genet2011-11-10T00:00:002011A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations.Authorship 8838376Authorship 8844583Authorship 884488429029263Pedroza M, To S, Assassi S, Wu M, Tweardy D, Agarwal SKRheumatology (Oxford, England)Role of STAT3 in skin fibrosis and transforming growth factor beta signalling. Rheumatology (Oxford). 2018 10 01; 57(10):1838-1850.Rheumatology (Oxford)2018-10-01T00:00:002018Role of STAT3 in skin fibrosis and transforming growth factor beta signalling.29128193Niravath P, Chen B, Chapman JW, Agarwal SK, Welschhans RL, Bongartz T, Kalari KR, Shepherd LE, Bartlett J, Pritchard K, Gelmon K, Hilsenbeck SG, Rimawi MF, Osborne CK, Goss PE, Ingle JNClinical breast cancerVitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27. Clin Breast Cancer. 2018 02; 18(1):78-87.Clin Breast Cancer2017-10-16T00:00:002017Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27.29112946Pedroza M, Welschhans RL, Agarwal SKPloS oneTargeting of cadherin-11 decreases skin fibrosis in the tight skin-1 mouse model. PLoS One. 2017; 12(11):e0187109.PLoS One2017-11-07T00:00:002017Targeting of cadherin-11 decreases skin fibrosis in the tight skin-1 mouse model.CHRISAMOSCHRIS AMOS13498AMOS, CHRISProfessor2Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate ProfessorD001323Chemicals & Drugs2615730.742869AutoantibodiesD001172Disorders1224050.721928Arthritis, RheumatoidD015820Chemicals & Drugs3246610.76342CadherinsD012595Disorders601340.88889Scleroderma, SystemicD012867Anatomy58112550.6475SkinAuthorship 92979610Authorship 9347271430407753Mahendra A, Yang X, Abnouf S, Adolacion JRT, Park D, Soomro S, Roszik J, Coarfa C, Romain G, Wanzeck K, Bridges SL, Aggarwal A, Qiu P, Agarwal SK, Mohan C, Varadarajan NArthritis & rheumatology (Hoboken, N.J.)Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA-Sequencing. Arthritis Rheumatol. 2019 04; 71(4):529-541.Arthritis Rheumatol2019-02-23T00:00:002019Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA-Sequencing.29771006Karmouty-Quintana H, Molina JG, Philip K, Bellocchi C, Gudenkauf B, Wu M, Chen NY, Collum SD, Ko J, Agarwal SK, Assassi S, Zhong H, Blackburn MR, Weng TArthritis & rheumatology (Hoboken, N.J.)The Antifibrotic Effect of A2B Adenosine Receptor Antagonism in a Mouse Model of Dermal Fibrosis. Arthritis Rheumatol. 2018 10; 70(10):1673-1684.Arthritis Rheumatol2018-08-06T00:00:002018The Antifibrotic Effect of A2B Adenosine Receptor Antagonism in a Mouse Model of Dermal Fibrosis.REETIJOSHIREETI JOSHI0.000000000000000.000000000000005590JOSHI, REETIClinical Assistant Professor2018-08-31NIHAGARWAL, SANDEEP K2012-09-15Cadherin-11 Regulation Of Dermal Fribrosis And Macrophage FunctionR01AR0620562013-07-31NIHAGARWAL, SANDEEP K2008-08-01Cadherin-11 Regulation of Fibroblast-like Synoviocytes in Synovial InflammationK08AR054404Principal InvestigatorPrincipal InvestigatorDepartment of MedicineDepartment of Pathology & ImmunologyImmunologyMedicine-Cardiovascular ScienceMedicine-Immunology, Allergy, RheumMedicine-PulmonaryPathologyBaylor College of MedicineGRACELOGRACE LO0.000000000000000.000000000000001734LO, GRACEAssociate ProfessorSRIDEVIDEVARAJSRIDEVI DEVARAJ0.000000000000000.000000000000001943DEVARAJ, SRIDEVIProfessorNIKOLAOSFRANGOGIANNISNIKOLAOS FRANGOGIANNIS29.70508570000000-95.401808700000001993FRANGOGIANNIS, NIKOLAOSAdjunct Professor6.314670.00234426289research areas3.279170.015108930coauthor of58.82569.2386660similar to1166selected publicationsMARTINLIDSKYMARTIN LIDSKY0.000000000000000.000000000000002422LIDSKY, MARTINAssociate Professor EmeritusDAVIDCORRYDAVID CORRY0.000000000000000.0000000000000064CORRY, DAVIDProfessorAuthorship 1117467Authorship 951084431269038Pedroza M, To S, Smith J, Agarwal SKPloS oneCadherin-11 contributes to liver fibrosis induced by carbon tetrachloride. PLoS One. 2019; 14(7):e0218971.PLoS One2019-07-03T00:00:002019Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride.Authorship 9542442Authorship 954298831439591Wu M, Skaug B, Bi X, Mills T, Salazar G, Zhou X, Reveille J, Agarwal SK, Blackburn MR, Mayes MD, Assassi SAnnals of the rheumatic diseasesInterferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis. Ann Rheum Dis. 2019 11; 78(11):1583-1591.Ann Rheum Dis2019-08-22T00:00:002019Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.31436586To S, Agarwal SKCurrent opinion in rheumatologyMacrophages and cadherins in fibrosis and systemic sclerosis. Curr Opin Rheumatol. 2019 11; 31(6):582-588.Curr Opin Rheumatol2019-11-01T00:00:002019Macrophages and cadherins in fibrosis and systemic sclerosis.true1ProfessorProfessortrue1InstructorInstructorIVANROSASIVAN ROSAS15330ROSAS, IVANProfessorSANAHASANSANA HASAN0.000000000000000.000000000000006205HASAN, SANAAssistant ProfessorMESIASPEDROZAMESIAS PEDROZA0.000000000000000.000000000000006358PEDROZA, MESIASInstructortrue1Clinical Assistant ProfessorClinical Assistant ProfessorAuthorship 992640432582860Ganugula R, Arora M, Zou D, Agarwal SK, Mohan C, Kumar MNVRScience advancesA highly potent lymphatic system-targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus. Sci Adv. 2020 06; 6(24):eabb3900.Sci Adv2020-06-12T00:00:002020A highly potent lymphatic system-targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus.SEBASTIANBRUERASEBASTIAN BRUERA15921BRUERA, SEBASTIANAssistant ProfessorAuthorship 10001451032978236Ventura MJ, Guajardo E, Clark EH, Bhairavarasu K, Kherallah RY, DiNardo AR, Ye X, Piedra PA, Atmar RL, Agarwal SKAnnals of the rheumatic diseasesCorrespondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort'. Ann Rheum Dis. 2022 Dec; 81(12):e239.Ann Rheum Dis2020-09-25T00:00:002020Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort'.Authorship 1189434Authorship 1008839233445131Bittar M, Agarwal SJoint bone spineSacroiliac involvement in Blau Syndrome. Joint Bone Spine. 2021 03; 88(2):105103.Joint Bone Spine2020-11-07T00:00:002020Sacroiliac involvement in Blau Syndrome.Authorship 1217231true1ProfessorProfessorAuthorship 1223266Authorship 10262386Authorship 1026595130975784Agarwal S, Dasgupta R, Paul TV, Thomas NBMJ case reportsAcral enlargement without growth hormone excess: a clinical conundrum. BMJ Case Rep. 2019 Apr 11; 12(4).BMJ Case Rep2019-04-11T00:00:002019Acral enlargement without growth hormone excess: a clinical conundrum.34312136Torrealba-Acosta G, Martin JC, Huttenbach Y, Garcia CR, Sohail MR, Agarwal SK, Wasko C, Bershad EM, Hirzallah MIBMJ case reportsAcute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine. BMJ Case Rep. 2021 Jul 26; 14(7).BMJ Case Rep2021-07-26T00:00:002021Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine.Authorship 1041072535211116To S, Chavula T, Pedroza M, Smith J, Agarwal SKFrontiers in immunologyCadherin-11 Regulates Macrophage Development and Function. Front Immunol. 2022; 13:795337.Front Immunol2022-02-08T00:00:002022Cadherin-11 Regulates Macrophage Development and Function.Authorship 149481Authorship 136043423811296Sendra VG, Lie A, Romain G, Agarwal SK, Varadarajan NMethods (San Diego, Calif.)Detection and isolation of auto-reactive human antibodies from primary B cells. Methods. 2013 Dec 01; 64(2):153-9.Methods2013-06-26T00:00:002013Detection and isolation of auto-reactive human antibodies from primary B cells.Authorship 1047029335650026Bruera S, Ventura MJ, Agarwal SK, Krause KJ, Lopez-Olivo MALupusThe utility of erythrocyte sedimentation rate, C-reactive protein, and procalcitonin in detecting infections in patients with systemic lupus erythematosus: A systematic review. Lupus. 2022 Sep; 31(10):1163-1174.Lupus2022-06-01T00:00:002022The utility of erythrocyte sedimentation rate, C-reactive protein, and procalcitonin in detecting infections in patients with systemic lupus erythematosus: A systematic review.Authorship 1047530335662129Chavula T, To S, Agarwal SKCells, tissues, organsCadherin-11 and Its Role in Tissue Fibrosis. Cells Tissues Organs. 2023; 212(4):293-303.Cells Tissues Organs2022-06-03T00:00:002022Cadherin-11 and Its Role in Tissue Fibrosis.true1Associate ProfessorAssociate ProfessorAuthorship 1063038436726783Bruera S, Chavula T, Madan R, Agarwal SKFrontiers in pharmacologyTargeting type I interferons in systemic lupus erythematous. Front Pharmacol. 2022; 13:1046687.Front Pharmacol2023-01-16T00:00:002023Targeting type I interferons in systemic lupus erythematous.Authorship 1066830836967086Ochsner SA, Pedroza M, Pillich RT, Krishnan V, Konicek BW, Dow ER, Park SY, Agarwal SK, McKenna NJThe Journal of investigative dermatologyIL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis. J Invest Dermatol. 2023 09; 143(9):1689-1699.J Invest Dermatol2023-03-24T00:00:002023IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis.Authorship 181001Authorship 18332Authorship 184031true1Associate Professor EmeritusAssociate Professor Emeritustrue1Adjunct ProfessorAdjunct ProfessorAuthorship 1070900337140198Bruera S, Sreedhar A, Agarwal SK, Muthukumar V, Geng Y, Lopez-Olivo MAInternational journal of rheumatic diseasesImmunosuppression for the treatment of pulmonary hypertension in patients with systemic lupus erythematosus: A?systematic review. Int J Rheum Dis. 2023 Jun; 26(6):1022-1028.Int J Rheum Dis2023-05-04T00:00:002023Immunosuppression for the treatment of pulmonary hypertension in patients with systemic lupus erythematosus: A?systematic review.Authorship 1072285337236672Yadav R, Kandasamy D, Agarwal S, Gamanagatti SBMJ case reportsMesenteric lipoblastomatosis: an uncommon fat-containing childhood tumour diagnosed on imaging. BMJ Case Rep. 2023 May 26; 16(5).BMJ Case Rep2023-05-26T00:00:002023Mesenteric lipoblastomatosis: an uncommon fat-containing childhood tumour diagnosed on imaging.true1Assistant ProfessorAssistant ProfessorAuthorship 161853Authorship 1090275938447248Chavula T, To S, Smith J, Pedroza M, Nimri J, Devaraj S, Wenderfer S, Vogel TP, Agarwal SKJournal of autoimmunityCADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus. J Autoimmun. 2024 Mar 05; 145:103197.J Autoimmun2024-03-05T00:00:002024CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus.true1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessorAuthorship 175402Authorship 26583Authorship 456905Authorship 14126919Authorship 143027924350901van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, Farina GA, Stifano G, Mathes AL, Cossu M, York M, Collins C, Wenink M, Huijbens R, Hesselstrand R, Saxne T, DiMarzio M, Wuttge D, Agarwal SK, Reveille JD, Assassi S, Mayes M, Deng Y, Drenth JP, de Graaf J, den Heijer M, Kallenberg CG, Bijl M, Loof A, van den Berg WB, Joosten LA, Smith V, de Keyser F, Scorza R, Lunardi C, van Riel PL, Vonk M, van Heerde W, Meller S, Homey B, Beretta L, Roest M, Trojanowska M, Lafyatis R, Radstake TRThe New England journal of medicineProteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014 Jan 30; 370(5):433-43.N Engl J Med2013-12-18T00:00:002013Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.24757152Wu M, Pedroza M, Lafyatis R, George AT, Mayes MD, Assassi S, Tan FK, Brenner MB, Agarwal SKArthritis & rheumatology (Hoboken, N.J.)Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis. Arthritis Rheumatol. 2014 Apr; 66(4):1010-21.Arthritis Rheumatol2014-04-01T00:00:002014Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.Authorship 35922Authorship 1456504Authorship 146493124741067Alimperti S, You H, George T, Agarwal SK, Andreadis STJournal of cell scienceCadherin-11 regulates both mesenchymal stem cell differentiation into smooth muscle cells and the development of contractile function in vivo. J Cell Sci. 2014 Jun 15; 127(Pt 12):2627-38.J Cell Sci2014-04-16T00:00:002014Cadherin-11 regulates both mesenchymal stem cell differentiation into smooth muscle cells and the development of contractile function in vivo.24917820Agarwal SKFrontiers in pharmacologyIntegrins and cadherins as therapeutic targets in fibrosis. Front Pharmacol. 2014; 5:131.Front Pharmacol2014-06-03T00:00:002014Integrins and cadherins as therapeutic targets in fibrosis.Authorship 678481Authorship 741687Authorship 5869614Authorship 5940111Authorship 602641Authorship 1515041925172494Le TT, Karmouty-Quintana H, Melicoff E, Le TT, Weng T, Chen NY, Pedroza M, Zhou Y, Davies J, Philip K, Molina J, Luo F, George AT, Garcia-Morales LJ, Bunge RR, Bruckner BA, Loebe M, Seethamraju H, Agarwal SK, Blackburn MRJournal of immunology (Baltimore, Md. : 1950)Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis. J Immunol. 2014 Oct 01; 193(7):3755-68.J Immunol2014-08-29T00:00:002014Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.Authorship 898609Authorship 6496923Authorship 660191Authorship 959902Authorship 990691Authorship 769982